Vertex announces UK approval for CASGEVY™
Congratulations to Vertex for their UK approval for CASGEVY™, a CRISPR/Cas9 gene-edited therapy, for...
read DetailsModality Solutions, a privately-held company that delivers integrated cold chain management solutions for highly regulated industries, has named Judy Tempel Principal Consulting Engineer for vaccine clinical trial operations.
HOUSTON, Tex. (PRWEB) July 21, 2015 — Modality Solutions, a company that delivers integrated cold chain management systems for highly regulated industries, is pleased to announce it has hired pharmaceutical veteran Judy Tempel as a principal consulting engineer. In her position as a Modality Solutions’ Principal Consulting Engineer, Judy is working on cold chain technical support, storage, distribution, and accountability for clinical trials. She is currently responsible for clinical trial operations for vaccines for infectious diseases in challenging emerging markets.
Tempel is a supply chain operations expert specializing in cold chain, warehouse systems and packaging. Prior to joining Modality Solutions, she completed a 23-year career at Eli Lilly and Company. In a series of roles with increasing scope and global responsibilities, she was instrumental in driving improvements in warehouse operations management, distribution and manufacturing. During her Lilly tenure, she held positions with technical and management responsibilities in both operations and global packaging engineering support.
During Tempel’s years in operations at Lilly, her responsibilities included finished pharmaceutical product warehousing, distribution and customer service for the entire US market from three regional distribution centers (Indiana, California and Connecticut). This position also included responsibility for central warehousing of API (active pharmaceutical ingredient), raw materials and packaging materials for Indianapolis-area GMP/GDP operations. Tempel’s other roles at Lilly included responsibility for antibiotic purification operations at an API manufacturing facility in Lafayette, Indiana, along with leading a team of engineers and scientists who provided packaging support for new product launch teams and approximately 20 global GMP packaging operations.
Tempel attended University of Notre Dame where she received her bachelor’s degree in Civil Engineering. She went on to obtain her Master of Science degree in Civil (Environmental) Engineering from Purdue University.
“We are pleased to have Judy join our team in overseeing clinical trials in high risk regions. She brings considerable experience in equipment qualification and process validation, packaging container closure system design and qualification, and technical transfer of product packaging to new locations,” said Modality Solutions President Gary Hutchinson. “Her individual contributions include development and implementation of common work practices globally, packaging process improvements, product protection initiatives (anti-counterfeiting and tamper evidence), and global IT systems implementation.”
For more information about Modality Solutions, visit http://www.modality-solutions.com.
About Modality Solutions
Founded in 2011 Modality Solutions delivers integrated cold chain management solutions for highly regulated industries. Its Advantage Transportation Simulation Laboratory™ helps companies test the effects of transportation environmental hazards on their formulations. Key areas of service are: ensure regulatory compliance; deliver cold chain thermal packaging design / qualification and controlled-environment logistics solutions; conduct transport simulation testing; decrease development cycle times for a faster route-to-market; and develop transport validation strategies to support global regulatory applications. Additional information can be found at http://www.modality-solutions.com.
Click here to view the online release.
Congratulations to Vertex for their UK approval for CASGEVY™, a CRISPR/Cas9 gene-edited therapy, for...
read DetailsCongratulations to Melinta Therapeutics for their FDA Approval of REZZAYO™ for the Treatment of...
read DetailsCongratulations to Iveric Bio for their FDA approval for IZERVAY™️️, a new treatment for...
read Details